Sunday, September 26, 2021 9:50:38 AM
There is no Real evidence suggesting one side is more correct then another. What we Believe is personal opinion.
Sure it does. Especially in the Medical field. In fact what is typical is certain milestones being required to be met. Like securing the IP. Duh. Dr. Koos, if in buyout discussions, would certainly be expected of securing the IP. Some purchasing companies cant even have the conversation until that point. He did what he needed to get the IP secured. And ill even go further in that Dr. Koos didnt have any specific Data to share until just now. Kind of necessary to continue any buyout discussions, at least i would think.
Look harder. Yes it does. All over. Loans right up to the DAY of acquisition.
I dont think anyone is actually saying that. More that its strong likelyhood. And absolutely not the only option. With as much IP as this company has in its possession. All the options are on the table with Regen. All of them.
Not all companies are for sale. Duh.
Of course. And the flip side is true… there are small biotech companies in this field that are obviously gearing towards buyout, that were bought out.
Here what still hasnt been mentioned. The undeniables. As in NR2F6 and Regen owned IP in and around it. Including several specific compounds that control NR2F6. Property of Regen. Undeniable.
Sometimes its Skil, Sometimes its Luc.
I Appreciate All Member Follows!
Desperate Sellers Become Desperate Buyers. Vice Versa
ALL IMHO.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM